Rolling Action Plan – our chemical evaluations list
The Rolling Action Plan lists our current and recently completed chemical evaluations. The Rolling Action Plan forms part of our approach to protecting human health and the environment.
What is the Rolling Action Plan?
The Rolling Action Plan is our work plan for prioritising chemicals for evaluation, which are selected based on the outcomes of our Evaluation Selection Analysis (ESA) process.
The plan lists our proposed, ongoing and recently completed chemical evaluations. It doesn't include evaluations initiated for chemicals under a current assessment certificate.
Our Evaluations Roadmap describes our strategic approach to protect human health and the environment by providing information and recommendations about managing the risks that arise from introducing and using industrial chemicals. By prioritising chemicals on the Inventory, our evaluations are more risk-proportionate, timely and targeted.
For each entry, the Rolling Action Plan includes the:
- subject of the evaluation – typically the chemical name or chemical group name
- reason for the evaluation
- time it takes to do the evaluation
- focus of the evaluation – chemical identity, and human health or the environment (or both)
- amendments to our list of evaluation candidates.
The publication of the subject, reason and time period within which the evaluation will be conducted satisfies the requirements of the Industrial Chemicals Act 2019 for initiating an evaluation.
During an Evaluation Selection Analysis (ESA) process we will identify chemicals that may pose a risk to human health and/or the environment. We will also identify chemicals that are unlikely to require further regulation to manage risks based on their human health and environmental hazards and exposures. This will allow us to publish Evaluation Statements for these chemicals and provide the rationale for not undertaking more detailed evaluations.
When do we update the Rolling Action Plan?
Generally, we will update the Rolling Action Plan after publishing our evaluations. We publish a notice on our website when we update it.
We will add details of newly initiated evaluations. Other changes to the rolling action plan may include amendments to the:
- evaluation subject
- time it takes to do the evaluation
- reason for the evaluation
We may need to update the Rolling Action Plan at other times. If we do, we’ll consult with interested parties and publish a notice on our website. These updates can happen for many reasons, including:
- an adverse event that warrants a chemical evaluation
- a stakeholder request to evaluate a chemical has been prioritised through ESA process
- a post-assessment obligation leads to an evaluation
- we are informed that new information will become available for the chemical that warrants a chemical evaluation
The identified chemicals covered by the subject of the evaluation may change as the evaluation progresses due to new information becoming available.
Completed evaluations remain on the Rolling Action Plan until the next set of evaluations are published.
Note: Please contact us if you have any information about any chemical listed on the Rolling Action Plan.
Rolling Action Plan
Evaluations under consultation, in progress and recently completed
We publish and maintain the following information as part of the Rolling Action Plan.
- Lists of evaluations that are in progress, currently open for public consultation or recently completed. Each evaluation could be for a single chemical or a group of chemicals.
- Downloadable spreadsheet of chemicals that are covered by an evaluation that is in progress, currently open for public consultation, or recently completed. These chemicals can change during the course of the evaluation if new information becomes available.
Download
Draft evaluations under public consultation
EvA ID |
Subject of evaluation |
Reason for evaluation |
Time period for evaluation |
Focus |
Amendments to RAP |
---|---|---|---|---|---|
EVA00041 |
1,4:7,10-Dimethanodibenzo[a,e]cyclooctene, 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro- (Dechlorane Plus) |
Evaluation Selection Analysis indicated a potential human health and environmental risk. |
30/06/2023 |
Health and Environment |
The timeframe for completion of this evaluation has been extended to enable consideration of the outcome from a critical long term aquatic toxicity study. The study is expected to be released to coincide with the international meeting that informs decisions under the Stockholm Convention. |
EVA00093 |
Chemicals not considered for in depth evaluation – Not commercially active in Australia |
Evaluation is needed to provide information on human health and environmental risks. |
30/06/2023 |
Health and Environment |
- |
EVA00096 |
Benzaldehyde |
Evaluation is needed to provide information on human health risks. |
30/06/2023 |
Health |
- |
EVA00097 |
Aniline and its salts |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
The subject of the evaluation has been changed to include aniline. The evaluation will consider newly identified information on aniline since the Inventory Multi-tiered Assessment and Prioritisation (IMAP) assessment was published in 2013. The IMAP assessment was conducted under the former National Industrial Chemicals Notification and Assessment Scheme. |
EVA00098 |
Benzene, 1-chloro-4-(trifluoromethyl)- |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00099 |
Peroxide, bis(1-methyl-1-phenylethyl) (dicumyl peroxide) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00102 |
Water soluble arsenic compounds |
Evaluation is needed to provide information on environmental risks. |
30/06/2023 |
Environment |
- |
EVA00103 |
Tocopherols and their salts and esters |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00104 |
Cresyl phosphates and xylyl phosphates |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
- |
EVA00108 |
Triphenyl phosphate and diphenyl phosphate |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
- |
EVA00109 |
Phenylenediamines |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
- |
EVA00111 |
Cyclohexanamine, 4,4'-methylenebis[2-methyl- |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00113 |
Propyl and butyl phenols |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00115 |
Polymers with pendant acrylates |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00117 |
Alkyl diphenyl oxide sulfonates |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
- |
EVA00119 |
Chemicals that are unlikely to require further regulation to manage risks to environment |
Evaluation is needed to provide information on environmental risks. |
31/12/2023 |
Environment |
- |
EVA00120 |
Chemicals that are unlikely to require further regulation to manage risks to human health |
Evaluation is needed to provide information on human health risks. |
31/12/2023 |
Health |
- |
Evaluations in progress
EvA ID |
Subject of evaluation |
Reason for evaluation |
Time period for evaluation |
Focus |
Amendments to RAP |
---|---|---|---|---|---|
EVA00091 | 1-methoxy-4-(2-propenyl)benzene (estragole) | Evaluation Selection Analysis indicated a potential human health risk. | 30/06/2023 | Health | - |
EVA00105 |
Water-soluble zinc salts |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2024 |
Environment |
The timeframe for completion of evaluation has been extended to enable provision of information to inform our risk assessment. |
EVA00121 |
Acetoin, cinnamaldehyde, diethylene glycol and ethylene glycol with end use in non-nicotine e-cigarettes (vaping products) |
Evaluation Selection Analysis indicated a potential human health risk. |
31/12/2023 |
Health |
- |
Recently completed evaluations
ID |
Subject |
Reason for evaluation |
Timeframe |
Focus |
Status Reason |
---|---|---|---|---|---|
1,4-Dioxane |
New information is available about human health risks. |
30/06/2022 |
Health |
Completed |
|
delta-Damascones |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
2-Propenamide, N,N-dimethyl- (dimethylacrylamide) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Straight run gas oils |
Evaluation is needed to provide information on human health risks. |
30/06/2022 |
Health |
Completed |
|
Exaltone and related macrocyclic musks |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
Octanamide, N-Hydroxy- |
To evaluate information submitted by industry to meet their obligation in the terms of the Inventory listing. |
31/12/2022 |
Health |
Completed |
|
Phenyl propanaldehydes |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
Lead and lead manufacturing byproducts |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl- (theophylline) |
Evaluation is needed to provide information on human health risks. |
30/06/2022 |
Health |
Completed |
|
Acetic acid, (4-nonylphenoxy)- |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Ethylene brassylate and zenolide |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
Musk tibetene and a structural analogue |
Evaluation Selection Analysis indicated a potential environmental risk. |
31/12/2022 |
Environment |
Completed |
|
1-Propene, 2,3,3,3-tetrafluoro- |
To evaluate information submitted by industry to meet their obligation in the terms of the Inventory listing. |
30/06/2022 |
Health |
Completed |
|
2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[(4-sulfo-1-naphthalenyl)azo]-, compounds |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
2-Propenoic acid, 2-methoxyethyl ester ((2-methoxyethyl acrylate) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Phenol, 4,4'-sulfonylbis- (BPS) |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
Long-chain alkyl hydroxyethyl imidazolines |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Benzene, 1,2,3,4,5-pentachloro- (PeCB) |
Evaluation is needed to provide information on human health and environmental risks. |
31/12/2022 |
Health and Environment |
Completed |
|
Benzene, hexachloro- (HCB) |
Evaluation is needed to provide information on human health and environmental risks. |
31/12/2022 |
Health and Environment |
Completed |
|
Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester (carbendazim) |
An evaluation or assessment recommended further evaluation of specific issues related to the chemical(s). |
31/12/2022 |
Health and Environment |
Completed |
|
Glycidyl acrylate and glycidyl methacrylate |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Benzalkonium halides |
Evaluation is needed to provide information on human health risks. |
30/06/2022 |
Health |
Completed |
|
Siloxanes substituted with 2-methoxyethanol |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Dodecylphenols |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Compounds of dioctyltin |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Compounds of dibutyltin |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Benzene, 1-chloro-2-nitro- (2-chloronitrobenzene) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
1-Propanol, 2,2-dimethyl-, tribromo derivative |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Benzene, 2,4-dichloro-1-nitro- (2,4-dichloronitrobenzene) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
Benzene, 1,4-dichloro-2-nitro- (2,5-dichloronitrobenzene) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2022 |
Health |
Completed |
|
4-tert-butylphenol and 4-tert-pentylphenol |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2022 |
Environment |
Completed |
|
Chemicals that are unlikely to require further regulation to manage risks to human health |
Evaluation is needed to provide information on human health risks. |
30/06/2022 |
Health |
Completed |
|
2,5-Furandione, telomer with ethenylbenzene and (1-methylethyl)benzene, hydrolyzed, 3-(dimethylamino)propyl imide, imide with polyethylene-polypropylene glycol 2-aminopropyl Me ether, 2-[(C10-16-alkyloxy)methyl]oxirane-quaternized, benzoates (salts) |
New information is available about the chemical’s identity. |
30/06/2022 |
Chemical Identity |
Completed |
|
1-bromo-3-chloropropane and 1,3-dibromopropane |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
Completed |
|
2-Propenamide, 2-methyl- (methacrylamide) |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
Completed |
|
Chemicals that are unlikely to require further regulation to manage risks to environment |
Evaluation is needed to provide information on environmental risks. |
30/06/2023 |
Environment |
Completed |
|
Chemicals that are unlikely to require further regulation to manage risks to human health |
Evaluation is needed to provide information on human health risks. |
30/06/2023 |
Health |
Completed |
|
Use of aluminium in antiperspirants |
Evaluation is needed to provide information on human health risks. |
30/06/2023 |
Health |
Completed |
|
Polymers incorporating glycidyl methacrylate |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
Completed |
|
Hydroquinone and p-benzoquinone |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
Completed |
|
Cadmium sulfide pigments |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
Completed |
|
Glyoxylic acid |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
Completed |
|
Carbamic acid, butyl-, 3-iodo-2-propynyl ester (IPBC) |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
Completed |
|
Long chain (C?10) alkyl benzene sulfonates |
Evaluation Selection Analysis indicated a potential human health risk. |
30/06/2023 |
Health |
Completed |
|
Lauryl (dodecyl) sulfates |
Evaluation Selection Analysis indicated a potential environmental risk. |
30/06/2023 |
Environment |
Completed |